Australia markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
149.12+1.21 (+0.82%)
At close: 04:00PM EDT
149.89 +0.77 (+0.52%)
Pre-market: 06:51AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close147.91
Open148.51
Bid149.36 x 900
Ask149.92 x 900
Day's range147.30 - 150.27
52-week range143.13 - 175.97
Volume9,337,714
Avg. volume7,515,895
Market cap359.346B
Beta (5Y monthly)0.53
PE ratio (TTM)20.07
EPS (TTM)7.43
Earnings date17 July 2024
Forward dividend & yield4.96 (3.33%)
Ex-dividend date20 May 2024
1y target est174.21
  • Insider Monkey

    10 Best Performing Biotech ETFs in 2024

    In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]

  • Zacks

    Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

    Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

  • Reuters

    RPT-Contaminated cough syrup in Africa no longer available - WHO

    A contaminated batch of Benylin Paediatric Syrup is no longer available in the African countries where it was sold, the World Health Organization said on Monday. Earlier this month, Nigeria recalled a batch of the children's cough and allergy medicine after tests found that it contained unacceptable levels of the toxin, diethylene glycol. Five other African countries have also pulled the product from shelves - Kenya, Rwanda, Tanzania, Zimbabwe and South Africa, where the drug was made.